Literature DB >> 8102927

Thermodynamics of antagonist binding to rat muscarinic M2 receptors: antimuscarinics of the pridinol, sila-pridinol, diphenidol and sila-diphenidol type.

M Waelbroeck1, J Camus, M Tastenoy, G Lambrecht, E Mutschler, M Kropfgans, J Sperlich, F Wiesenberger, R Tacke, J Christophe.   

Abstract

1. We studied the effect of temperature on the binding to rat heart M2 muscarinic receptors of antagonists related to the carbon/silicon pairs pridinol/sila-pridinol and diphenidol/sila-diphenidol (including three germanium compounds) and six structurally related pairs of enantiomers [(R)- and (S)-procyclidine, (R)- and (S)-trihexyphenidyl, (R)- and (S)-tricyclamol, (R)- and (S)-trihexyphenidyl methiodide, (R)- and (S)-hexahydro-diphenidol and (R)- and (S)-hexbutinol]. Binding affinities were determined in competition experiments using [3H]-N-methyl-scopolamine chloride as radioligand. The reference drugs were scopolamine and N-methyl-scopolamine bromide. 2. The affinity of the antagonists either increased or decreased with temperature. van't Hoff plots were linear in the 278-310 degrees K temperature range. Binding of all antagonists was entropy driven. Enthalpy changes varied from large negative values (down to -29 kJ mol-1) to large positive values (up to +30 kJ mol-1). 3. (R)-configurated drugs had a 10 to 100 fold greater affinity for M2 receptors than the corresponding (S)-enantiomers. Enthalpy and entropy changes of the respective enantiomers were different but no consistent pattern was observed. 4. When silanols (R3SiOH) were compared to carbinols (R3COH), the affinity increase caused by C/Si exchange varied between 3 and 10 fold for achiral drugs but was negligible in the case of chiral drugs. Silanols induced more favourable enthalpy and less favourable entropy changes than the corresponding carbinols when binding. Organogermanium compounds (R4Ge) when compared to their silicon counterparts (R4Si) showed no significant difference in affinity as well as in enthalpy and entropy changes. 5. Exchange of a cyclohexyl by a phenyl moiety was associated with an increase or a decrease in drug affinity (depending on the absolute configuration in the case of chiral drugs) and generally also with a more favourable enthalpy change and a less favourable entropy change of drug binding. 6. Replacement of a pyrrolidino by a piperidino group and increasing the length of the alkylene chain bridging the amino group and the central carbon or silicon atom were associated with either an increase or a decrease of entropy and enthalpy changes of drug binding. However, there was no clear correlation between these structural variations and the thermodynamic effects. 7. Taken together, these results suggest that hydrogen bond-forming OH groups and, to a lesser extent, polarizable phenyl groups contribute significantly to the thermodynamics of interactions between these classes of muscarinic antagonists and M2 muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102927      PMCID: PMC2175680          DOI: 10.1111/j.1476-5381.1993.tb13578.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 2.  Thermodynamic analysis of the drug-receptor interaction.

Authors:  R B Raffa; F Porreca
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

3.  Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.

Authors:  G A Weiland; K P Minneman; P B Molinoff
Journal:  Nature       Date:  1979-09-13       Impact factor: 49.962

4.  [Sila drugs. 29. Bioisosteric C/Si exchange in parasympatholytics of the pridinol type].

Authors:  R Tacke; M Strecker
Journal:  Arch Pharm (Weinheim)       Date:  1984-03       Impact factor: 3.751

5.  Effects of temperature and ethanol on agonist and antagonist binding to rat heart muscarinic receptors in the absence and presence of GTP.

Authors:  M Waelbroeck; P Robberecht; P Chatelain; P De Neef; J Christophe
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

6.  Muscarinic acetylcholine receptor: thermodynamic analysis of the interaction of agonists and antagonists.

Authors:  J P Gies; B Ilien; Y Landry
Journal:  Biochim Biophys Acta       Date:  1986-10-31

7.  Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.

Authors:  M Waelbroeck; M Gillard; P Robberecht; J Christophe
Journal:  Mol Pharmacol       Date:  1986-10       Impact factor: 4.436

8.  Stereoselectivity of the enantiomers of trihexyphenidyl and its methiodide at muscarinic receptor subtypes.

Authors:  G Lambrecht; R Feifel; U Moser; A J Aasen; M Waelbroeck; J Christophe; E Mutschler
Journal:  Eur J Pharmacol       Date:  1988-10-11       Impact factor: 4.432

9.  Temperature effect on subclasses of muscarinic receptors in rat colon, heart and cerebral cortex.

Authors:  F Muzio; S Malandrino; M Ferrari; G Tonon
Journal:  Life Sci       Date:  1986-07-28       Impact factor: 5.037

10.  The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.

Authors:  G J Kilpatrick; N el Tayar; H Van de Waterbeemd; P Jenner; B Testa; C D Marsden
Journal:  Mol Pharmacol       Date:  1986-09       Impact factor: 4.436

View more
  2 in total

1.  Thermodynamically distinct high and low affinity states of the A(1) adenosine receptor induced by G protein coupling and guanine nucleotide ligation states of G proteins.

Authors:  A Lorenzen; L Guerra; F Campi; H Lang; U Schwabe; P A Borea
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

2.  Thermodynamic analysis of agonist and antagonist binding to the chicken brain melatonin receptor.

Authors:  N W Chong; D Sugden
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.